Experimental animal models and their use in understanding cysticercosis: A systematic review

被引:6
|
作者
Sitali, Muloongo C. [1 ]
Schmidt, Veronika [2 ]
Mwenda, Racheal [3 ]
Sikasunge, Chummy S. [3 ]
Mwape, Kabemba E. [4 ]
Simuunza, Martin C. [5 ]
da Costa, Clarissa P. [6 ]
Winkler, Andrea S. [7 ]
Phiri, Isaac K. [4 ]
机构
[1] Univ Zambia, Sch Vet Med, Dept Biomed Sci, Lusaka, Zambia
[2] Univ Oslo, Ctr Global Hlth, Inst Hlth & Soc, Oslo, Norway
[3] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia
[4] Univ Zambia, Sch Vet Med, Dept Clin Studies, Lusaka, Zambia
[5] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia
[6] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[7] Tech Univ Munich, Ctr Global Hlth, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
来源
PLOS ONE | 2022年 / 17卷 / 07期
关键词
TAENIA-SOLIUM CYSTICERCOSIS; EXPERIMENTAL-INFECTION; SEROLOGICAL DIAGNOSIS; CIRCULATING ANTIGENS; IMMUNE-RESPONSE; TAIWAN TAENIA; SAGINATA; PIGS; DEVELOP; NEUROCYSTICERCOSIS;
D O I
10.1371/journal.pone.0271232
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Cysticercosis and Neurocysticercosis (NCC) can be studied using several animal species in experimental models which contributes to the understanding of the human form of the disease. Experimental infections of Taenia spp. are vital in explaining the modes of transmission of the parasite and helps the understanding of transmission of the parasite in humans and thus may be useful in designing therapeutic and immune-prophylactic studies to combat the disease. Thus, this systematic review aims to explore the existing experimental animal models to the understanding of cysticercosis in both humans and animals and elucidate the risk factors of cysticercosis and identify the Taenia spp. used in these models. Methodology We systematically identified all publications from the Web of Science, Google Scholar, and Pubmed regarding experimental animal models using Taenia spp. that cause cysticercosis in both humans and animals. 58 studies were identified for eligibility. Of these, only 48 studies met the inclusion criteria from which data extraction was done and presented descriptively. Results Pigs, cattle, gerbils, mice, rats, voles, monkeys, cats, dogs, and goats were used in which T. solium, T. saginata, T. saginata asiatica, T. crassiceps and T. asiatica were studied. The routes used to induce disease were; oral, intravenous, subcutaneous, intramuscular, intraperitoneal, intraarterial, intracranial, intraduodenal, and surgical routes using eggs, oncospheres, and proglottids. Besides, the establishment of infection using eggs and oncospheres was affected by the route used to induce infection in the experimental animals. The cysticerci recovery rate in all the experimental studies was low and the number of animals used in these experiments varied from 1 to 84. Although not analysed statistically, sex, age, and breed of animals influenced the cysticerci recovery rate. Additionally, the cysticerci recovery rate and antibody-antigen levels were shown to increase with an increase in the dose of oncospheres and eggs inoculated in the animals. Contrasting results were reported in which the cysticerci recovery rate decreased with an increase in the dose of eggs inoculated. Conclusion This review describes the various animal experiments using Taenia species that cause cysticercosis highlighting the animals used, age and their breed, the routes of infection used to induce disease and the sample size used, and the cysticerci recovery rate in these animal models.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] A systematic review of animal models for experimental neuroma
    Toia, Francesca
    Giesen, Thomas
    Giovanoli, Pietro
    Calcagni, Maurizio
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2015, 68 (10): : 1447 - 1463
  • [2] Experimental animal models for brain abscess: a systematic review
    Mariager, Theis
    Bjarkam, Carsten
    Nielsen, Henrik
    Bodilsen, Jacob
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 2022,
  • [3] Experimental Animal Models of Traumatic Coagulopathy: A Systematic Review
    van Zyl, Natasha
    Reade, Michael C.
    Fraser, John F.
    [J]. SHOCK, 2015, 44 (01): : 16 - 24
  • [4] Animal experimental models of ischemic limbs - A systematic review
    Lovasova, Veronika
    Bem, Robert
    Chlupac, Jaroslav
    Dubsky, Michal
    Husakova, Jitka
    Nemcova, Andrea
    Fronek, Jiri
    [J]. VASCULAR PHARMACOLOGY, 2023, 153
  • [5] Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models
    Koning, Rutger
    van Roon, Marian A.
    Brouwer, Matthijs C.
    van de Beek, Diederik
    [J]. BRAIN COMMUNICATIONS, 2024, 6 (03)
  • [6] Use of nanoparticles in animal models for prostate cancer treatment: a systematic review
    Selzle, Michele
    Almeida, Alexandre Moreira de
    Neves, Marcelo Barbosa
    Goncalves, Alessandra de Figueiredo
    Aydos, Ricardo Dutra
    Ramalho, Rondon Tosta
    [J]. ACTA CIRURGICA BRASILEIRA, 2023, 38
  • [7] Use of phytocanabinoids in animal models of Parkinson's disease: Systematic review
    Alves, Amanda de Deus Ferreira
    Dias, Fernanda Carolina Ribeiro
    Cadena, Pabyton Gonsalves
    Silva-Jr, Valdemiro Amaro
    [J]. NEUROTOXICOLOGY, 2024, 105 : 34 - 44
  • [8] The use of aliskiren as an antifibrotic drug in experimental models: A systematic review
    Marin, Thaina Altarejo
    Bertassoli, Bruno Machado
    de Siqueira de Carvalho, Alzira Alves
    Feder, David
    [J]. DRUG DEVELOPMENT RESEARCH, 2020, 81 (01) : 114 - 126
  • [9] Dental implants in large animal models with experimental systemic diseases: A systematic review
    Matos, Flavia Gomes
    Stremel, Anna Clara Abreu
    Lipinski, Leandro Cavalcante
    Cirelli, Joni Augusto
    dos Santos, Fabio Andre
    [J]. LABORATORY ANIMALS, 2023, 57 (05) : 489 - 503
  • [10] Understanding arsenic carcinogenicity by the use of animal models
    Wanibuchi, H
    Salim, EI
    Kinoshita, A
    Shen, J
    Wei, M
    Morimura, K
    Yoshida, K
    Kuroda, K
    Endo, G
    Fukushima, S
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 198 (03) : 366 - 376